Transplant Connect
Transplant Connect builds the iTransplant software platform for organ, eye, tissue, and birth tissue donation-transplant workflows, serving hospitals, transplant centers, and organ procurement organizations as the donation-transplant division of InVita Healthcare Technologies.
- Company typePrivate
- Founded2004
- HeadquartersSanta Monica, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Transplant Connect does
Transplant Connect is a US-based medical software company that builds the iTransplant platform for the organ, eye, tissue, and birth tissue donation-transplant workflow. Its software is deployed by hospitals, transplant centers, and organ procurement organizations to manage donor registration, organ matching, transplant coordination, and chain-of-custody for tissue implants, with RFID-based tracking for hospital tissue implant software. Complementary modules include iReferral, an automated donor referral engine, and the iTransplant Mobile App, which provides HIPAA-compliant chat, image sharing, and team geo-tracking for field transplant staff.
The company was founded in 2004 by John Piano and has operated for approximately two decades as a specialist vendor in a narrow clinical vertical. In 2022 it received investment from InVita Healthcare Technologies, and in 2023 it was fully integrated as InVita's Donation-Transplant division, gaining access to broader R&D capacity and cross-sell opportunities into InVita's adjacent human biologics software (blood center, DNA, hospital tissue implant). Following the integration, founder John Piano moved into a strategic role on the InVita executive team and board, and Wade Liu was promoted to Chief Product Officer of InVita and General Manager of the Donation-Transplant division.
Transplant Connect operates as a B2B enterprise software business serving regulated healthcare buyers. Its go-to-market is direct enterprise sales to hospitals and OPOs; pricing is not publicly disclosed. The business model is consistent with vertical SaaS in a mission-critical, regulated workflow: high switching costs, long deployment cycles, and expansion revenue driven by module attach (iReferral, mobile app, RFID) rather than new logo acquisition, given the small universe of US OPOs and transplant centers.
Transplant Connect firmographics
Firmographics- Name
- Transplant Connect
- Legal name
- Transplant Connect
- Website
- https://transplantconnect.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Transplant Connect builds the iTransplant software platform for organ, eye, tissue, and birth tissue donation-transplant workflows, serving hospitals, transplant centers, and organ procurement organizations as the donation-transplant division of InVita Healthcare Technologies.
- Ownership category
- akta.pro rank
Transplant Connect industry classification
Industry- Product category
- Healthcare Donation-Transplant Software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
Keywords
Where Transplant Connect is headquartered
LocationHeadquarters
- HQ city
- Santa Monica
- HQ country
- United States
- HQ region
- North America
Markets served
Transplant Connect business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Transplant Connect product offering
Product offeringCore offering
Transplant Connect develops and sells the iTransplant Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform, a comprehensive software solution for managing donor registration, organ matching, and transplant workflows. The offering is complemented by the iReferral automated donor referral module and the iTransplant Mobile App, which provides HIPAA-compliant chat, image sharing, and logistics/team geo-tracking for field transplant teams. The platform is sold to hospitals, transplant centers, and other healthcare organizations to connect and streamline the donation-transplant ecosystem.
Product overview
Transplant Connect operates as the Donation-Transplant division under InVita Healthcare Technologies, offering a unified product ecosystem centered on the iTransplant Platform. The core offering is the iTransplant Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform, complemented by the iReferral automated donor referral module and the iTransplant Mobile App. Together, these products connect and streamline the donation-transplant ecosystem, enabling partners to manage organ, eye, tissue, and birth tissue donation workflows through a comprehensive digital solution.
Differentiator
Problem solved
Functional benefit
Brands
- iTransplant: Industry-leading and award-winning Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform.
- iReferral
- iTransplant Mobile App
Products and services
- iTransplant Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform
- iReferral Automated Donor Referral Technology
- iTransplant Mobile App
Companies that use Transplant Connect
Customer profileSegments1 record
Ideal customer profiles1 record
Transplant Connect technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Transplant Connect partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights5 records
Transplant Connect competitors and assessment
Company assessmentDirect peers
- MediGO: Provides real-time organ transportation and logistics technology to OPOs and transplant centers. Comparable to Transplant Connect because both serve the same donation-transplant customer base with mission-critical software, though MediGO focuses on logistics while Transplant Connect focuses on donor/recipient workflow.
- LifeLogics: Blood center and biologics management software vendor that operates alongside Transplant Connect under the InVita Healthcare Technologies umbrella. Comparable as a sibling product serving adjacent human biologics workflows for hospitals and blood centers.
Broad incumbents
- Epic Systems: Dominant US hospital EHR vendor whose systems underpin the IT estates of most transplant centers. Comparable as the broad incumbent platform that Transplant Connect must integrate with and against which it must justify standalone spend.
- Oracle Health (Cerner): Major hospital EHR vendor with deep penetration in large health systems and academic transplant centers. Comparable as a broad incumbent whose transplant-adjacent workflows could expand to encroach on Transplant Connect's niche.
- MEDITECH: Hospital EHR vendor serving community and mid-size hospitals, including transplant programs. Comparable as a broad incumbent EHR that Transplant Connect integrates with at the hospital level.
- Haemonetics: Blood and plasma component management company with software and hardware solutions for hospital transfusion services. Comparable as a broader human biologics vendor serving adjacent workflows that Transplant Connect touches via InVita's blood center unit.
Emerging players
- CareDx: Transplant diagnostics and digital health company serving transplant centers and post-transplant patients. Comparable as a focused transplant ecosystem player whose center-facing software strategy overlaps with Transplant Connect's hospital customer base.
- OrganOx: Medical device company developing organ preservation technology (metra) used during transplant logistics. Comparable as a transplant-ecosystem technology vendor whose success drives transplant volumes that benefit Transplant Connect's platform.
- TransMedics: Organ transplant systems company providing OCS (Organ Care System) technology for lung, heart, and liver preservation and transport. Comparable as a transplant-ecosystem technology vendor whose growth expands the underlying transplant market Transplant Connect serves.
Others
- Veloxis Pharmaceuticals: Specialty pharma company focused on transplant immunosuppression (Envarsus XR). Comparable as an adjacent transplant-ecosystem participant serving the same end-clinicians and transplant centers, though via therapeutics rather than software.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Transplant Connect social profiles
Digital presenceTransplant Connect financial estimates
Financial estimateRevenue estimate
Valuation estimate
Transplant Connect leadership team
Management profileNumber of profiles
Profiles2 records
Transplant Connect funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Transplant Connect M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Transplant Connect
What does Transplant Connect do?
Transplant Connect develops and sells the iTransplant Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform, a comprehensive software solution for managing donor registration, organ matching, and transplant workflows. The offering is complemented by the iReferral automated donor referral module and the iTransplant Mobile App, which provides HIPAA-compliant chat, image sharing, and logistics/team geo-tracking for field transplant teams. The platform is sold to hospitals, transplant centers, and other healthcare organizations to connect and streamline the donation-transplant ecosystem.
Is Transplant Connect a public or private company?
Transplant Connect is a private company. It is classified as corporate owned and is currently acquired.
When was Transplant Connect founded?
Transplant Connect was founded in 2004. It employs 11 to 50 people.
Where is Transplant Connect based?
Transplant Connect is headquartered in Santa Monica, United States, in the North America region.
Who are Transplant Connect's main competitors?
Direct peers on record are MediGO and LifeLogics. Broad incumbents are Epic Systems, Oracle Health (Cerner), MEDITECH and Haemonetics. Emerging players are CareDx, OrganOx and TransMedics. Veloxis Pharmaceuticals is listed as an others.
Does Transplant Connect have an API?
No public API is recorded for Transplant Connect.
What industry is Transplant Connect in?
Transplant Connect's product category is Healthcare Donation-Transplant Software. Its primary akta.pro industry code is HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring. Its NAICS code is 54151 and its SIC code is 8000.